Sun Pharma Advanced Research Company Limited

Clinical trials sponsored by Sun Pharma Advanced Research Company Limited, explained in plain language.

Sun Pharma Advanced Research Company Limited SPARC NSE

Research-focused subsidiary of Sun Pharma, developing novel drug delivery and specialty pharmaceuticals.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New cancer drug SBO-154 enters human testing for advanced tumors

Disease control Recruiting now

This early-phase trial tests a new biologic drug called SBO-154 in 177 people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. The main goals are to check safety, find the right dose, and get a first look at whether the drug can shrink…

Phase 1 • Sponsor: Sun Pharma Advanced Research Company Limited • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC

Sun Pharma Advanced Research Company Limited

New cancer drug SBO-154 enters human testing for advanced tumors